A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology

Abstract excerpt

Recent updates in the classification of central nervous system (CNS) tumors have increased the need for molecular testing. Assessment of multiple alterations in parallel, complex combinations of gene sequence and chromosomal changes, as well as therapy prediction by identification of actionable mutations are the major challenges. We here report on a customized next generation sequencing (NGS)-based DNA panel...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Chromatin Remodeling and Cancer
• Share to Glioma Diagnosis and Treatment